Φορτώνει......
Immunostimulatory nanoparticle incorporating two immune agonists for the treatment of pancreatic tumors
Pancreatic ductal adenocarcinoma (PDAC) is a highly malignant disease, where even surgical resection and aggressive chemotherapy produce dismal outcomes. Immunotherapy is a promising alternative to conventional treatments, possessing the ability to elicit T cell-mediated killing of tumor cells and p...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | J Control Release |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
2020
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7906920/ https://ncbi.nlm.nih.gov/pubmed/33188827 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jconrel.2020.11.014 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|